Wall Street futures rise as tariff jitters ease; US GDP and PCE inflation data up next
22 January 2026
2 mins read

Wall Street futures rise as tariff jitters ease; US GDP and PCE inflation data up next

New York, Jan 22, 2026, 06:01 (EST) — Premarket

U.S. stock index futures climbed early Thursday, signaling a stronger open for Wall Street following yesterday’s bounce. Dow e-mini futures jumped 179 points, S&P 500 e-mini futures advanced 41 points, and Nasdaq 100 e-mini futures rose 220.75 points as of 4:26 a.m. ET.

Stocks jumped Wednesday after U.S. President Donald Trump posted on Truth Social that a framework for a future Greenland deal means the tariffs set for Feb. 1 won’t be implemented, easing worries of another transatlantic trade clash. The Dow climbed 1.21%, the S&P 500 rose 1.16%, and the Nasdaq gained 1.18%, led by banks and energy sectors.

The snapback is key as traders have started viewing policy headlines as a fresh risk. In the next few hours, data releases could shake up rate expectations. At the World Economic Forum in Davos, Trump ruled out seizing Greenland by force and later confirmed tariffs wouldn’t be necessary. Meanwhile, a signal from the U.S. Supreme Court regarding Fed Governor Lisa Cook kept investors wary about the ongoing battle over the Fed’s independence.

The market took a sharp turn this week. Tuesday saw the three major indexes suffer their steepest single-day losses in three months as tariff threats rattled risk assets, pulling the S&P 500 and Nasdaq below their 50-day moving averages — a key technical indicator often seen as a warning sign. The CBOE Volatility Index, or Wall Street’s “fear gauge,” surged to its highest close since late November. Reuters

Thursday’s spotlight is on the data schedule. At 8:30 a.m. EST, the Bureau of Economic Analysis will roll out its updated estimate for third-quarter 2025 GDP, along with industry-level GDP figures and revised corporate profits. Then, at 10:00 a.m., personal income and outlays for October and November are expected, including the all-important PCE price index that the Fed watches closely. Weekly jobless claims also arrive at 8:30 a.m. Eastern.

The focus shifts to the Fed next week, with its policy meeting set for Jan. 27-28. Traders will scrutinize inflation and growth data for hints on the duration of restrictive rates.

Earnings will take center stage, with Intel set to report after Thursday’s close. The results will test the chipmaker’s turnaround narrative and offer a key read on the broader sector. “It’s the most optimistic, I think, people have felt about the company in a long time,” noted Ryuta Makino, an analyst at Intel investor Gabelli Funds. He highlighted expectations for stronger server demand, despite Intel facing stiff competition from AMD and others. Reuters

The risk for equities now is that any fresh policy flare-up hits before the data comes through. This week’s sharp swings revealed how swiftly tariff chatter can drown out the fundamentals, and investors haven’t had much chance to regain confidence since Tuesday’s sell-off.

Thursday kicks off with the 8:30 a.m. GDP update and jobless claims, then the 10:00 a.m. personal income and outlays report, which includes the key PCE inflation gauge. Intel’s earnings hit after the closing bell.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Abbott Laboratories (ABT) Results Fuel Stock Rally Amid Valuation Discussion
    July 22, 2026, 10:21 PM EDT. Abbott Laboratories (ABT) posted higher sales in its recent earnings, though net income and EPS fell. Shares rose 12.66% in the last 7 days and 14.51% over 30 days, although still down 19.02% for the year to date. The stock is viewed as 13.7% undervalued, with a fair value estimate of $116.54, supported by gains in emerging markets and biosimilars. Diagnostic pricing pressures and utilization patterns are seen as important risks.
ServiceNow stock price ticks up after hours as OpenAI tie-up and Oppenheimer cut sharpen focus on Jan. 28 earnings
Previous Story

ServiceNow stock price ticks up after hours as OpenAI tie-up and Oppenheimer cut sharpen focus on Jan. 28 earnings

Bloom Energy stock price slips as big-holder filings land ahead of Feb. 5 earnings
Next Story

Bloom Energy stock price slips as big-holder filings land ahead of Feb. 5 earnings